CNST
Constellation Pharmaceuticals, Inc.
CNST
CNST
Delisted
CNST was delisted on the 14th of July, 2021.
131 hedge funds and large institutions have $1.22B invested in Constellation Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
39% less call options, than puts
Call options by funds: $4.39M | Put options by funds: $7.23M
Holders
131
Holding in Top 10
7
Calls
$4.39M
Puts
$7.23M
Top Buyers
| 1 | +$12.6M | |
| 2 | +$9.77M | |
| 3 | +$9.02M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.66M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$6.49M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$9.29M | |
| 3 | -$8.19M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.12M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.56M |